Deerland Enzymes, a leading international enzyme-based dietary supplement formulator and contract manufacturer, presented its latest technology for gluten sensitivities, Glutalytic™, at SupplySide West.
Dr. John Deaton, vice president of technology, presented to a standing-room-only audience of show attendees on the rise of gluten-related sensitivities and the various digestive issues gluten can cause. Deaton went on to explain the research and science behind Deerland Enzymes’ approach to creating a more effective enzyme supplement to address these issues.
“Traditional supplements to aid in gluten digestion utilize the DPPIV (dipeptidyl peptidase IV) enzyme, which is indeed an effective exopeptidase that breaks down the gluten protein from its ‘ends’,” Deaton explained. “However, the fastest way to break down gluten is to break down its peptide bonds both from within and the ends,” he added. “Deerland Enzymes’ newest technology, Glutalytic, contains both endopeptidases and exopeptidases, producing a much more rapid degradation of gluten.”
Dr. Deaton’s presentation generated a great amount of excitement among the attendees, prompting many to visit Deerland Enzymes’ booth to obtain more information about Glutalytic.
For those who were not able to attend the show, the presentation will be available by webinar on request. For more information, contact Deerland Enzymes at 800.697.8179 or [email protected]